Verbo Pharma SRL
Verbo Pharma reported total assets of 940,708 € at the end of the 2026 financial year (annual accounts filed with the NBB on 28 Sep 2026).
The score of Verbo Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +9 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verbo Pharma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 28 Sep 2026
- Year ended 31 Mar 2025filed on 07 Oct 2025
- Year ended 31 Mar 2024filed on 07 Oct 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
- Year ended 31 Mar 2022filed on 30 Aug 2022
Verbo Pharma's financial analysis
- Solvency83.9%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verbo Pharma
Verbo Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.012.142
- VAT number
- BE0898012142
- Peppol
- Registered · 0208:0898012142 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 May 2008
- Registered office
- 3110 Rotselaar
- Latest accounts
- 2026 · filed on 28 Sep 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Verbo Pharma (SRL) has been based in Rotselaar since 2008, active in: business and other management consultancy activities. For 2026, it reports a net profit of 10,886 € and equity of 789,198 €; its revenue is not published. Its solvency stands at 83.9%, above the median of its sector (58.9%).
Companies similar to Verbo Pharma
Companies in the same business, of comparable size and area, outside its group.
- Tommy Pasteels Management Business and other management consultancy activities Beveren-Kruibeke-Zwijndrecht · balance sheet 942,283 €
- Melacon Business and other management consultancy activities Kortrijk · balance sheet 937,522 €
- Airdk Business and other management consultancy activities Izegem · balance sheet 936,319 €
- Maleal Business and other management consultancy activities Fernelmont · balance sheet 945,345 €
- Iccanobif Business and other management consultancy activities Antwerp · balance sheet 935,421 €
- Helmico Business and other management consultancy activities Waregem · balance sheet 932,714 €
- Vanderpijpen - Vantieghem Business and other management consultancy activities Aalst · balance sheet 949,820 €
- Castor Business and other management consultancy activities Kontich · balance sheet 953,497 €
Frequently asked questions about Verbo Pharma
What is the revenue of Verbo Pharma?
Verbo Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Verbo Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0898012142 for Verbo Pharma, if the company is VAT-registered. Its company number (CBE) is 0898.012.142.
Where is the registered office of Verbo Pharma?
According to the CBE register, the registered office of Verbo Pharma is in 3110 Rotselaar.
What is the equity of Verbo Pharma?
At the close of the 2026 financial year, the equity of Verbo Pharma amounts to 789,198 €, a solvency of 83.9% of total assets.
Who manages Verbo Pharma?
The register lists 2 active mandates at Verbo Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verbo Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →